Developing The Right Oral Dosage Form For Pediatric Medicines

When it comes to the development of drug products for use by pediatric populations, the selection of the right formulation is critical. The developmental status of the target patient population will not only strongly influence the dosage form and strength, but also other formulation factors including taste or odor masking and swallowability. Working with a CDMO that has decades of expertise in the development of pediatric dosage forms can be critical to ensuring regulatory and commercial success. In this interview with Ashish Guha, Associate Director of Oral Formulations at Evonik Health Care, we review some of the key factors that need to be considered during initial formulation development.